Comparison

M40 acetate(143896-17-7 free base) European Partner

Item no. TMO-TP1992L-100mg
Manufacturer TargetMol
Amount 100 mg
Quantity options 100 mg 100 mg 10 mg 10 mg 1 mg 1 mg 200 mg 200 mg 25 mg 25 mg 50 mg 50 mg 5 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles C[C@@H](O)[C@H](NC([C@@H](NC(CN)=O)CC1=CNC2=CC=CC=C21)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N3CCC[C@H]3C(N4CCC[C@H]4C(N5CCC[C@H]5C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)CC(C)C)=O)C)=O)CC(C)C)=O)C)=O)=O)=O)=O)=O)CC(C)C)=O)CC(C)C)=O)CC6=CC=C(O)C=C6)=O)=O)C)=O)CO)=O)CC(N)=O)=O)CC(C)C)=O.CC(O)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Neuropeptide Y Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
2041, 38
Description
M40 acetate is a potent, non-selective galanin receptor antagonist (Ki values are 1.82 and 5.1 nM at GAL1 and GAL2 respectively) that inhibits galanin (1-29) binding in rat brain in vitro (IC50 = 3 - 15 nM). Attenuates the antidepressant effects of fluoxetine and blocks galanin-induced food intake in vivo. Also exhibits weak partial agonist activity at peripheral GAL2 receptors at doses > 100 nM.
Pathways
GPCR/G Protein|||Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close